000			02222 a2200577 4500
005			20250513215202.0
264		0	_c20001010
008			200010s 0 0 eng d
022			_a0269-2813
024	7		_a10.1046/j.1365-2036.2000.00804.x _2doi
040			_aNLM _beng _cNLM
100	1		_aPilotto, A
245	0	0	_aPantoprazole versus one-week Helicobacter pylori eradication therapy for the prevention of acute NSAID-related gastroduodenal damage in elderly subjects. _h[electronic resource]
260			_bAlimentary pharmacology & therapeutics _cAug 2000
300			_a1077-82 p. _bdigital
500			_aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_a2-Pyridinylmethylsulfinylbenzimidazoles
650	0	4	_aAge Factors
650	0	4	_aAged
650	0	4	_aAging _xphysiology
650	0	4	_aAmoxicillin _xadministration & dosage
650	0	4	_aAnti-Bacterial Agents _xadministration & dosage
650	0	4	_aAnti-Inflammatory Agents, Non-Steroidal _xadverse effects
650	0	4	_aAnti-Ulcer Agents _xadministration & dosage
650	0	4	_aBenzimidazoles _xadministration & dosage
650	0	4	_aClarithromycin _xadministration & dosage
650	0	4	_aDrug Therapy, Combination
650	0	4	_aDuodenal Diseases _xchemically induced
650	0	4	_aEndoscopy
650	0	4	_aFemale
650	0	4	_aHelicobacter Infections _xcomplications
650	0	4	_aHelicobacter pylori _xdrug effects
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aOmeprazole _xanalogs & derivatives
650	0	4	_aPantoprazole
650	0	4	_aPenicillins _xadministration & dosage
650	0	4	_aProton Pump Inhibitors
650	0	4	_aStomach Diseases _xchemically induced
650	0	4	_aSulfoxides _xadministration & dosage
700	1		_aDi Mario, F
700	1		_aFranceschi, M
700	1		_aLeandro, G
700	1		_aBattaglia, G
700	1		_aGermanà, B
700	1		_aMarin, R
700	1		_aValerio, G
773	0		_tAlimentary pharmacology & therapeutics _gvol. 14 _gno. 8 _gp. 1077-82
856	4	0	_uhttps://doi.org/10.1046/j.1365-2036.2000.00804.x _zAvailable from publisher's website
999			_c10879881 _d10879881